These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 17704532
21. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer. Sun Q, Liu C, Zhong H, Zhong B, Xu H, Shen W, Wang D. Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768 [Abstract] [Full Text] [Related]
22. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM. Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531 [Abstract] [Full Text] [Related]
27. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. Tedesco KL, Berlin J, Blanke CD, Teng M, Choy H, Roberts J, Beauchamp RD, Leach S, Wyman K, Tarpley J, Shyr Y, Caillouette C, Chakravarthy B. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1364-70. PubMed ID: 15817338 [Abstract] [Full Text] [Related]
29. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus. Zhang X, Shen L, Li J, Li Y, Li J, Jin M. Am J Clin Oncol; 2008 Feb 01; 31(1):29-33. PubMed ID: 18376224 [Abstract] [Full Text] [Related]
31. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma]. Zhang XD, Shen L, Li J, Li Y, Li J, Zhang XT, Jin ML. Zhonghua Zhong Liu Za Zhi; 2007 Jun 01; 29(6):474-7. PubMed ID: 17974288 [Abstract] [Full Text] [Related]
32. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, Tang L, Ilson DH, Minsky BD, Rusch VW, American Joint Committee on Cancer. J Clin Oncol; 2007 Feb 10; 25(5):507-12. PubMed ID: 17290058 [Abstract] [Full Text] [Related]
33. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK. Ann Thorac Surg; 2006 Aug 10; 82(2):480-4; discussion 484-5. PubMed ID: 16863749 [Abstract] [Full Text] [Related]
34. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR. J Thorac Cardiovasc Surg; 2008 Jun 10; 135(6):1228-36. PubMed ID: 18544359 [Abstract] [Full Text] [Related]
35. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T. Gynecol Oncol; 2009 Aug 10; 114(2):215-8. PubMed ID: 19446318 [Abstract] [Full Text] [Related]